The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease

Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients

(2008) Macaulay A. C. Onuigbo et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis

(2008) M.A.C. Onuigbo et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontarget--a call for more circumspection

(2008) M.A.C. Onuigbo   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Late Onset Azotemia from RAAS Blockade in CKD Patients with Normal Renal Arteries and No Precipitating Risk Factors

(2008) Macaulay A.C. Onuigbo et al.   RENAL FAILURE

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on Streptozotocin-Induced Diabetic Nephropathy

(2008) Saniye Sen et al.   RENAL FAILURE